ConcertAI

The 2024 ISPOR-EU meeting is almost here (Nov 17-20), and we are excited to share our latest advancements with you! If you will be attending the event in Barcelona, Spain, ConcertAI scientists would love to show you how ConcertAI solutions provide outcomes researchers with deep and robust clinical RWD solutions to power your evidence generation activities contributing to more informed care strategies that can improve patient outcomes. ? ConcertAI will present?ground breaking evidence completed with the National Death Index database validating a new gold standard of mortality capture through combination of multiple real world datasets. Take advantage of the unique opportunity to attend our Poster Session this year at ISPOR-EU, "Addition of Open Administrative Claims Significantly Improves Capture of Mortality in Electronic Health Record (EHR) – Focused Real-World Data (RWD)" Monday, November 18th, 10:30AM-1:30PM Interested in learning more about our poster? Visit the link below: https://hubs.ly/Q02Ym3jl0 Yanina (Yana) Natanzon, Sheenu Chandwani, Mark S. Walker, Lukas Slipski MPH MA #PatientOutcomes #ISPOREU2024 #EvidenceGeneration #ClinicalRWD

Attending ISPOR EU this year? Explore how ConcertAI's innovative solutions are driving advancements in health economics and outcomes research. Discover how our comprehensive real-world data and advanced analytics are enhancing patient-centered research and supporting digital transformation in healthcare. Visit the link below to set up a meeting with one of our attending scientists today! https://lnkd.in/gB2FxW9Y #ISPOREurope #RWD #PatientCentricity #EvidenceGeneration Sheenu Chandwani, Yanina (Yana) Natanzon, Mark S. Walker, Lukas Slipski MPH MA

A key factor in making precision oncology a routine and fully realized part of clinical practice in all settings of care is the importance of making it easier for patients to receive biomarker testing and assuring that testing is reimbursed. In this blog post, three of ConcertAI's top leaders focus on the importance of Biomarker Bills -- legislation that targets putting state-level mandates in place to assure that biomarker testing, with appropriate evidence and utility, are reimbursed. To date, 30 states have advanced such legislation with 20 of them signing these bills into law. In addition, they also explore how ConcertAI and CancerLinQ? solutions can help close this gap in diagnosis and care. Read more on our blog: https://lnkd.in/gGtzJadF #Oncology #PrecisionOncology #Biomarkers

We had an amazing time at our Family Day event in our India office, bringing together employees and their families for a day of fun and connection. The day was filled with activities for all ages, including exciting games and a vibrant Kids’ Zone where the little ones could play freely. Families enjoyed a festive atmosphere with special gift distributions that added a touch of joy to the occasion. We took a moment to recognize our dedicated team members with service awards, celebrating their hard work and commitment. Afterward, everyone gathered for a delicious lunch, sharing laughs and stories, and creating lasting memories during our photo sessions. A big thank you to everyone who participated and contributed to making this day unforgettable! Are you Interested in being a part of a strong community at ConcertAI? Take a look at our recent job postings via the link below: https://hubs.ly/Q02WtGrM0 #FamilyDay #Community #JoinOurTeam #Hiring #Opportunity #Jobs #NowHiring

So it’s a wrap for HLTH Inc. 2024! As a transition out, we appreciated being spotlighted in NVIDIA's Digital Health: AI Agents for Healthcare partner montage. Thanks again to our colleagues at NVIDIA and Kimberly Powell in particular.? ConcertAI’s CARAai is revolutionizing research by turning digital health data into powerful insights that enhance clinical trials, enabling researchers to discover cures for diseases once deemed unbeatable—fast-tracking us toward a healthier tomorrow. This collaboration underscores ConcertAI's commitment to harnessing the power of AI to drive innovation in healthcare and improve patient outcomes worldwide. https://hubs.ly/Q02W8BjF0 Read more about how ConcertAI is advancing translational and clinical development solutions in collaboration with NVIDIA Healthcare: https://hubs.ly/Q02W8yCh0 #AIagents #digitalhealth #agenticAI

In case you missed it, last week we had the privilege in being featured in NVIDIA Healthcare's presentation by Head of Healthcare, Kimberly Powell, at the 2024 HLTH Inc. Conference MainStage Session. Over recent months, our collaboration with NVIDIA AI has significantly propelled the development of a multi-LLM NIMs-based and Agentic AI architecture within our CARAai? Platform. This innovative solution, integral to our Oncology Clinical Development Suite, spans from study design to patient-to-trial matching and is deployable across major cloud platforms. By replacing legacy OCR, NLP, and AI systems, the CARAai workflows achieve exceptionally low latency and accuracy, paralleling expert human analysis of EMR notes and documents. This advancement ensures a more inclusive patient consideration across all care settings for potential life-saving clinical trials. Interested in experiencing ConcertAI's latest solutions? Request a Demo today: https://lnkd.in/eNrMgkPC #HLTH2024 #HLTHUSA #AIinHealthcare #ArtificialIntelligence #ClinicalTrials

We are excited to showcase a poster at SNOMED International CT EXPO this year. Cancer is the second biggest cause of death in US, diagnosing early and providing targeted treatment at the right time is the key to improve outcomes. According to CDC, cancer death rates decrease across all races, gender, and population from 2009 to 2019 due to development of new treatment modalities. Advancements in clinical trials and medications plays a vital role in overall survival and remission. At ConcertAI, we are enabling provider organizations to conduct clinical trials more efficiently by using highly sophisticated technology solutions powered by generative AI capabilities. ConcertAI's Digital Trial Solution not only help in clinical trial process, but it is also creating a platform for semantic and meaningful health data exchange using standards like SNOMEDCT. Our technologies promote semantic interoperability and significantly reduces manual data entry at the point of care and gives more time for medical monitors to focus more on patient care. Register online to check out our ePoster October 24-25 | Seoul, Korea + Online: https://hubs.ly/Q02Vts4q0 Contributors: Shirin H. Zaidi, Jiby Joseph MD, MS, Pyeush Gurha, Jen Flach, Jacqui Thomas #ePoster #ClinicalTrials #AI #GenAI #GenerativeAI #Oncology #Research

ConcertAI is attending HLTH Inc. 2024 next week, where we will be at the forefront of discussions on AI's transformative role in Healthcare and Life Sciences. Join us as we break new ground in how artificial intelligence is advancing research, improving clinical trials, and speeding up medical innovations alongside our esteemed collaborations at NVIDIA Healthcare. You won't want to miss this exciting Main Stage keynote: The Evolution of Digital Health and Generative AI in Healthcare - Monday, October 21, 9:40 a.m. PT featuring NVIDIA’s VP of Healthcare and Life Sciences, Kimberly Powell We look forward to the opportunity to connect and see how we're shaping the future of healthcare! Learn more our latest offerings: https://hubs.ly/Q02TS9TS0 Jeff Elton Claudio D’Ambrosio #HLTH2024 #ConcertAI #AIInHealthcare #LifeSciences #MedicalInnovation #NVIDIAHealthcare

This Thursday, don't miss the opportunity to hear from Jeff Elton and others as they share their insights during a dynamic panel "HealthTech Disruption: AI Investment Strategies" this year at HPE NYC 2024. We look forward to seeing you there! Time & Date: Thursday, October 17 at 2:20 pm ET Location: The Glasshouse, New York | 660 12th Avenue, 6th Floor To register and learn more about the conference, visit: https://hubs.ly/Q02TtPNY0 List of Speakers: Eric Berger, Partner, Bain & Company Jeff Elton, PhD, Chief Executive Officer, ConcertAI Joshua Kellar, Managing Director and Senior Partner, Boston Consulting Group Jo N., Founder and Managing Partner, Invidia Capital Management Fazeela Abdul Rashid, Partner, Revolution Growth Moderator: Shawn Helms, Partner, McDermott Will & Emery Moderator: Dale Van Demark, Partner, McDermott Will & Emery

This Monday at ACPE 2024 as Daiichi Sankyo US’s Shunsuke Takada presents research utilizing ConcertAI’s Patient360?. Discover how machine learning is refining lung cancer patient classification to improve clinical trial selection and research accuracy. Don’t miss this insightful poster session in Tokyo on October 14th, showcasing the power of AI in enhancing patient data for better health outcomes. Learn more about the event, session, and the transformative potential of AI in healthcare: https://hubs.ly/Q02Tf_ds0 #ACPE24 #Pharmacoepidemiology #Patient360 #AIinHealthcare